QA

Labviva Positions for Next Stage of Commercial Growth with Key Executive Hires

Retrieved on: 
Tuesday, May 2, 2023

Labviva , the AI-driven life sciences procurement platform, today announced the appointment of three new executives to drive key functions.

Key Points: 
  • Labviva , the AI-driven life sciences procurement platform, today announced the appointment of three new executives to drive key functions.
  • Emily Nault joins Labviva as Senior Vice President, Platform Sales and Commerce, Jonathan Sheffi will join Labviva as Vice President, Strategic Marketing and Neal Karasic as Vice President of Product.
  • "We’re thrilled to welcome Emily, Jonathan, and Neal to the Labviva team to support growing market demand," said Siamak Baharloo, CEO of Labviva.
  • Labviva has seamlessly integrated scientific content and products from hundreds of brands and suppliers, to create a unique and efficient onboarding and purchasing experience.

Tachyum Completes Porting of Software for Prodigy Tape-Out

Retrieved on: 
Tuesday, May 2, 2023

Tachyum ™ today announced its latest milestone of officially entering the final phase of test and development for the Prodigy Universal Processor.

Key Points: 
  • Tachyum ™ today announced its latest milestone of officially entering the final phase of test and development for the Prodigy Universal Processor.
  • Prodigy is currently running ported software on its software emulation platform.
  • Once all Quality Assurance testing is successfully completed on FPGA, the Prodigy chip will be ready for tape-out this year.
  • I am very excited about the progress that Tachyum has made thus far and look forward to entering the next phase of success.”

New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers

Retrieved on: 
Tuesday, May 2, 2023

Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.

Key Points: 
  • Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.
  • PIMS' process definition capabilities already allow pharma manufacturers to view their processes with their specific parameters for all major process steps and across manufacturing batches.
  • This latest release adds process definition versioning and approvals to help alleviate manual Standard Operating Procedure (SOP) requirements and enhance quality assurance (QA).
  • "Having their critical process data in PIMS already gives them the assurance of data integrity and these new enhancements now make it even easier to complete QA and validation steps."

New process definition capabilities in PIMS enhance quality assurance and validation for pharma manufacturers

Retrieved on: 
Tuesday, May 2, 2023

Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.

Key Points: 
  • Providing contextualized access to aggregated manufacturing data, PIMS offers a single source of data truth for efficient gathering, sharing and analysis of critical manufacturing process and quality data to support Continued Process Verification (CPV), investigations and process optimization.
  • PIMS' process definition capabilities already allow pharma manufacturers to view their processes with their specific parameters for all major process steps and across manufacturing batches.
  • This latest release adds process definition versioning and approvals to help alleviate manual Standard Operating Procedure (SOP) requirements and enhance quality assurance (QA).
  • "Having their critical process data in PIMS already gives them the assurance of data integrity and these new enhancements now make it even easier to complete QA and validation steps."

Variations to Marketing Authorisations Training Course: Including Filing Tips and Strategies With Information and Advice on Creating a Global Dossier and Implementation Periods - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 2, 2023

The "Variations to Marketing Authorisations Training Course" conference has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Variations to Marketing Authorisations Training Course" conference has been added to ResearchAndMarkets.com's offering.
  • It is a key post-marketing responsibility of the marketing authorisation holder (MAH) to keep dossiers up to date, and changes must be submitted as variations to the appropriate regulatory authority.
  • The programme will include filing tips and strategies with information and advice on creating a global dossier and implementation periods.
  • It will also be of interest to anyone with an involvement in the variations process including QA, clinical safety and pharmacovigilance personnel.

Appvance Launches Redesigned Corporate Brand Identity and Website

Retrieved on: 
Tuesday, May 2, 2023

SANTA CLARA, Calif. , May 2, 2023 /PRNewswire/ -- Appvance, the leader in generative AI for QA since 2017, introduces its new corporate brand identity today. The new look, which includes updates to the logomark, website, color scheme, and illustrations, ties into the company's mission to improve quality, performance, and security of applications while transforming the efficiency, speed and output of development and testing teams in Enterprise organizations.

Key Points: 
  • SANTA CLARA, Calif. , May 2, 2023 /PRNewswire/ -- Appvance, the leader in generative AI for QA since 2017, introduces its new corporate brand identity today.
  • The new color palette represents the Appvance brand at its most essential - innovative, visionary, trustworthy and credible.
  • Our AIQ platform offers a unique approach to serving our customers and positioning them for success " said Andre Liao, Appvance CEO.
  • Visit our website at appvance.ai, to see how our new branding has come to life.

Vaco Opens a New State-of-the-Art Digital Operations Center in San Francisco

Retrieved on: 
Monday, May 1, 2023

Vaco, a global professional services firm, has announced the expansion of their San Francisco-based technology consulting and managed services practice with the opening of a 50,000 square-foot digital operations center in San Ramon, California.

Key Points: 
  • Vaco, a global professional services firm, has announced the expansion of their San Francisco-based technology consulting and managed services practice with the opening of a 50,000 square-foot digital operations center in San Ramon, California.
  • “Vaco is committed to providing world-class digital outsourcing services to our clients as part of our ongoing dedication to the digital content space,” said Jimmy J. Jhanda, managing partner of Vaco’s San Francisco office.
  • We remain vigilant in looking for meaningful ways to support and connect this community of people.”
    This is the fourth global digital operations center Vaco has opened.
  • “This new digital operations center is about Vaco’s commitment to excellence while meeting the needs of our clients and our team members,” said Haseeb Wahedy, Vaco client partner and engagement director.

LambdaTest Adds More Intuitive Features to Its End-to-End Test Orchestration Platform HyperExecute

Retrieved on: 
Friday, April 28, 2023

LambdaTest , an intelligent omnichannel digital experience testing cloud platform, has added a host of new features to its end-to-end test execution and orchestration platform HyperExecute .

Key Points: 
  • LambdaTest , an intelligent omnichannel digital experience testing cloud platform, has added a host of new features to its end-to-end test execution and orchestration platform HyperExecute .
  • With the framework and language-agnostic HyperExecute, QA and development teams can now move from ‘how to test’ to ‘what to test’.
  • Users, in order to distribute their Tosca test cases, can set up the project via HyperExecute and run the execution lists directly from the HyperExecute platform.
  • A continuous test execution and orchestration platform that is fast, reliable, secure, and scalable is the need for businesses today.

DecisionHealth offers a suite of solutions, training, and resources to help home health agencies navigate OASIS-E changes in 2023 and beyond

Retrieved on: 
Thursday, April 27, 2023

BRENTWOOD, Tenn., April 27, 2023 /PRNewswire-PRWeb/ -- With the release of OASIS-E, the latest version of the home health data set, CMS has introduced 27 new items and has removed older questions and replaced them with either one or more related questions. Home health agencies report they are spending an average of 25 extra minutes per OASIS assessment thanks to the sweeping changes. DecisionHealth offers a suite of solutions to help agencies adapt, minimize negative productivity impacts, and enable staff to answer OASIS-E items more efficiently and accurately to drive Home Health Value-Based Purchasing (HHVBP) payments in the future.

Key Points: 
  • Home health agencies report they are spending an average of 25 extra minutes per OASIS assessment thanks to the sweeping changes.
  • DecisionHealth offers a suite of solutions to help agencies adapt, minimize negative productivity impacts, and enable staff to answer OASIS-E items more efficiently and accurately to drive Home Health Value-Based Purchasing (HHVBP) payments in the future.
  • Home health agencies report they are spending an average of 25 extra minutes per OASIS assessment thanks to the sweeping changes.
  • DecisionHealth is continuously rolling out new solutions and is dedicated to helping agencies achieve success throughout the remainder of 2023 and beyond.

Small Cell 5G Network Market to be worth $125.5 Billion by 2030: Grand View Research, Inc.

Retrieved on: 
Thursday, April 27, 2023

The deployment of next-generation small cell 5G networks is estimated to witness significant growth over the forecast period.

Key Points: 
  • The deployment of next-generation small cell 5G networks is estimated to witness significant growth over the forecast period.
  • This is attributed to a robust deployment of a small cell 5G network with a centralized baseband unit controllable architecture.
  • Grand View Research has segmented the global small cell 5G network market on the basis of component, network model, network architecture, deployment mode, frequency type, end-use, and region.
  • Small Cell 5G Network Market - Component Outlook (Revenue, USD Million, 2019 - 2030)